Late-Breakers To Look Out For At ASCO 2020

Pfizer, Merck KGaA, Merck & Co, Amgen and AstraZeneca To Present

ASCO 2020, which takes place from 29-31 May, will necessarily depart from its predecessors in location, content and delivery. Here, with input from Biomedtracker and Datamonitor Healthcare, we take a look at what can be expected during this year’s late-breaking clinical trial sessions.    

T-cells - lymphocytes
• Source: Shutterstock

Abstracts for this year’s American Society of Clinical Oncology dropped as usual two weeks ahead of the 29-31 May meeting, but this year the curtain has been raised on a different stage setting: there are fewer abstracts but more complete data released than for previous ASCO conferences.

Pharma Intelligence’s Biomedtracker and Datamonitor Healthcare’s Pre-ASCO Report in 2019 covered over 2,000 poster sessions compared with just over 400...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from ASCO

More from Conferences